Cancer - A degenerative disorder?

European Journal of Surgical Oncology

Volumn 24, Issue 5, 1998, Pages 362-366

  Rew, David A ^a,b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Aldoplasia; Degeneration; Genome; Neoplasia; Regulation

Indexed keywords

AGING; ANEUPLOIDY; APOPTOSIS; CANCER; CELL PROLIFERATION; DEGENERATIVE DISEASE; DETERIORATION; DNA REPAIR; GENE MUTATION; GENETIC REGULATION; GENOTYPE; HUMAN; NOMENCLATURE; PRIORITY JOURNAL; REGULATOR GENE; REVIEW; THERAPY;

EID: 0031756077     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(98)91907-2     Document Type: Article

References (44)

1. Lundblad V, Wright WE. Telomeres and telomerase: a simple picture becomes complex. Cell 1996; 87: 369-75.
2. Lundblad V. The end replication problem: more than one solution. Nature 1997; 3(11): 1198-9.
3. Wynford-Thomas D, Kipling D. Cancer and the knockout mouse. Nature 1997; 389: 551-2.
4. Rennie J. Immortal's enzyme. Sci Am 1994; 271: 8-9.
5. Bishop M. Oncogenes. Sci Am 1982; 246: 69-78.
6. Dang CV. c-Myc oncoprotein function. Biochim Biophys Acta 1991; 1072: 103-13.
7. Miden MD, Pawson AJ. Oncogenes. In: Tannock I, Hill RP (eds) The Basic Science of Oncology, 2nd edn. New York: McGraw Hill, 1992; 61-87.
8. Hunter A. Oncoprotein networks. Cell 1997; 88: 333-46.
9. Vile RG. p53: a gene for all tumours? Br Med J 1993; 307: 1226-7.
10. Donehower LA, Bradley A. The tumour suppressor p53. Biochim Biophys Acta 1993; 1155: 181-205.
11. Harris CC. p53: at the crossroads of molecular carcinogenesis and risk assessment. Science 1993; 262: 1980-1.
12. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323-31.
13. Soussi T, Caron de Fromentel C, May P. Structural aspects of the p53 protein in relation to gene evolution. Oncogene 1990; 5: 945-52.
14. Koshland DE. Molecule of the year: the DNA repair enzyme. Editorial. Science 1994; 266: 1925-7.
15. Modrich P. Mismatch repair, genetic stability and cancer. Science 1994; 266: 1957-8.
16. Hanawalt PC. Transcription-coupled repair and human disease. Science 1994; 266: 1957-8.
17. Sancar A. Mechanisms of DNA excision repair. Science 1994; 266: 1954-6.
18. Liu LF. DNA topoisomerase poisons as antitumour drugs. Ann Rev Biochem 1989; 58: 351-75.
19. Smith PJ. Topoisomerase inhibitors: new twists to anticancer drug action. Oncol Today 1991; 3: 4-9.
20. Kinzler KW, Vogelstein B. Gatekeepers and caretakers. Nature 386: 761-3.
21. Langauer C, Kinzler RW, Vogelstein B. Genetic instability in colorectal cancer. Nature 1997; 386: 623-6.
22. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994; 266: 1821-8.
23. Peters G. Cell cycle: stifled by inhibitions. Nature 1994; 371: 204-5.
24. Lynch HT, Smyrk TC, Watson P, et al. Genetics, natural history, tumour spectrum, and pathology of hereditary non-polyposis colorectal cancer. Gastroenterology 1993; 104: 1535-49.
25. Hedley DW. Flow cytometric assays of anticancer drug resistance. Ann NY Acad Sci 1993; 677: 341-53.
26. Garrod DR. Cell to cell and cell to matrix adhesion. Br Med J 1993; 306: 703-5.
27. Menger MD, Vollmar B. Review: adhesion molecules as determinants of disease: from molecular biology to surgical research. Br J Surg 1996; 83: 588-601.
28. Fidler IJ, Ellis LM. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994; 79: 185-8.
29. Folkman J. Angiogenesis in cancer, vascular and rheumatoid disease. Nature Med 1995; 1: 27-31.
30. Jiang WG, Puntis MCA, Hallett MB. Molecular and cellular basis for cancer invasion and metastasis: implications for treatment. Br J Surg 1994; 81: 1576-80.
31. Rew DA. Significance of aneuploidy. Br J Surg 1994; 81: 1416-22.
32. Rew DA. Heterogeneity, biodiversity and bioperversity in human solid tumours. Eur J Surg Oncol 1996; 22: 469-73.
33. Kerr JFR, Wyllie AH, Currie AH. Apoptosis, a basic biological phenomenon with wider implications in tissue kinetics. Br J Cancer 1972; 26: 239-45.
34. Nagata S. Apoptosis by death factor. Cell 1997; 88: 355-65.
35. Wyllie AH. Apoptosis. Br J Cancer 1993; 67: 205-8.
36. Duke RC. Ojcius DM, Young JD. Cell suicide in health and disease. Sci Am 1996; Dec: 48-55.
37. Williams GT. Programmed cell death: apoptosis and oncogenesis. Cell 1991; 65: 1097-8.
38. Fearon ER. Human cancer syndromes: clues to the origin and nature of cancer. Science 1997; 278: 1043-50.
39. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal tumour development. New Engl J Med 1988; 319: 525-32.
40. Stanbridge EJ. Identifying tumour suppressor genes in colorectal cancer. Science 1990; 247: 12-3.
41. Ford D, Easton DF. The genetics of breast and ovarian cancer. Br J Cancer 1995; 72: 805-12.
42. Greene MH. Genetics of breast cancer. Mayo Clin Proc 1997; 72: 54-65.
43. Maher ER. Genetics of urological cancers. Br Med Bull 1994; 50: 698-707.
44. Flanders TY, Foulkes WD. Pancreatic adenocarcinoma: epidemiology and genetics. J Med Genet 1996; 33: 889-98.